Etrolizumab Demonstrated no Difference Among Doses in Symptomatic and Endoscopic-Based Evaluation of Remission in Anti-TNF-α Naïve Patients in a Post hoc Analysis of the Phase 2 Ulcerative Colitis Trial (Eucalyptus)
JOURNAL OF CROHNS & COLITIS（2017）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要